Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Name: Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
Published: 2022
License: Public Domain

Roswell Park Cancer Institute · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

anatomic stage iv breast cancer ajcc v8, metastatic malignant neoplasm in the brain, metastatic triple-negative breast carcinoma, prognostic stage iv breast cancer ajcc v8, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Related documents